Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

New diabetes form found by Norwegian researchers

next article
05.01.2006

 


A research group in Bergen has discovered a new form of diabetes. In addition to high blood sugar levels, the disease is characterised by a decrease in pancreatic functioning and reduced fat absorption in the intestine. The discovery may have an impact on the treatment of more usual forms of diabetes.


Researchers from Haukeland University Hospital and the University of Bergen published an article in Nature Genetics, one of the highest ranked journals in the field of biomedicine. The article describes two families where doctors have diagnosed an unusually high incidence of diabetes among family members.

The pancreas has two distinct and maybe inter-related functions; the production and secretion of enzymes involved in digestion in the intestine (pancreatic juice) and the production of hormones including insulin, which is involved in the control of blood sugar levels. Problems with the enzyme-producing function of the pancreas are observed in diabetic patients, but the relationship between the different pancreatic functions, the contributing genetic factors and the disease are as yet poorly understood.

The discovery of a new form of diabetes stemmed from the closer study of the family members. This revealed that those family members with diabetes also had disrupted function of the pancreas’ digestive enzyme production; in particular the production of carboxyl ester lipase, which is a major component of pancreatic juice. The researchers undertook genetic studies and showed that the dysfunction was due to mutations of the gene that encodes for this particular pancreatic enzyme.

In their conclusions, the researchers underlined that carboxyl ester lipase exists in many different forms and that future investigations of patients with diabetes should also study the presence of these variants.

Prof. Paal R. Njoelstad | Source: alphagalileo
Further information: kliniskmedisin.uib.no/index.php?valg=sql&id=30
www.uib.no

next article

More articles from Health and Medicine:

nachricht Interferon alpha can delay full onset of type I diabetes
03.07.2009 | University of Texas Health Science Center at Houston

nachricht Infants should be screened for hip trouble
03.07.2009 | American Academy of Orthopaedic Surgeons

All articles from Health and Medicine >>>

B2B Search

Product / Service
Company / Organisation

Latest News

The least sea ice in 800 years

03.07.2009 | Earth Sciences

Astronomer's new guide to the galaxy: largest map of cold dust revealed

03.07.2009 | Physics and Astronomy

Interferon alpha can delay full onset of type I diabetes

03.07.2009 | Health and Medicine

VideoLinks

Event News

New Worlds - New Solutions - Research and Innovation as a Basis for Developing Europe in a Global Context

29.06.2009 | Event News

6th BMBF Forum for Sustainability "Research for Sustainability - One Step Further"

19.06.2009 | Event News

2nd ISPIM Innovation Symposium - Stimulating Recovery The Role of Innovation Management

02.06.2009 | Event News